Crispr Therapeutics shares owned by Cetera Investment Advisers
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Cetera Investment Advisers
from 13F filings
Historical chart of Cetera Investment Advisers investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Cetera Investment Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Cetera Investment Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $1.4M | 27k | 54.01 |
| 2024-03-31 | $2.3M | 34k | 68.16 |
| 2023-09-30 | $261k | 5.7k | 45.39 |
| 2023-06-30 | $320k | 5.7k | 56.14 |
| 2023-03-31 | $372k | 8.2k | 45.23 |
| 2022-12-31 | $350k | 8.6k | 40.65 |
| 2022-09-30 | $434k | 6.6k | 65.33 |
| 2022-06-30 | $490k | 8.1k | 60.76 |
| 2022-03-31 | $491k | 7.8k | 62.73 |
| 2021-12-31 | $528k | 7.0k | 75.82 |
| 2021-09-30 | $808k | 7.2k | 111.96 |
| 2021-06-30 | $1.0M | 6.4k | 161.83 |
| 2021-03-31 | $563k | 4.6k | 121.81 |
| 2020-12-31 | $783k | 5.1k | 153.20 |
More positions owned by Cetera Investment Advisers
View all positions for Cetera Investment Advisers